Skip to content

Increasing use of smoking cessation services with risk information and taster sessions

A randomised trial to increase the uptake of smoking cessation services using personal tailored risk information and taster sessions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN76561916
Enrollment
2520
Registered
2009-12-10
Start date
2010-04-01
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Interventions

Control group: A standard generic letter sent from the surgery advertising the NHS stop smoking service and asking the smoker to contact the service to make an appointment to see an advisor. Interve

Sponsors

University College London (UCL) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All current smokers: 1. Willing to participate and returning the signed consent form 2. Aged 16 years and over, either sex 3. Able to read English 4. Motivated to quit 5. Have not previously attended the NHS services

Exclusion criteria

Exclusion criteria: Exclusion criteria are minimal because the aim is to recruit all smokers into the services. However, smokers younger than 16 will be excluded because of the need for parental consent to participate for this age group, and any patients identified who are considered by the GP to be unsuitable for the project, e.g. severely or terminally ill, will be excluded.

Design outcomes

Primary

MeasureTime frame
The proportion of people entering the smoking cessation service (i.e. attending the first session of a 6-week course) over a period of 6 months from the receipt of the invitation letter. Self-reported attendance data will be validated by records of attendance at the NHS services.

Secondary

MeasureTime frame
1. 7-day point prevalent abstinence at the 6-month follow-up, validated by salivary cotinine for all participants reporting abstinence in both the intervention and control groups 2. Prolonged periods of abstinence of 7 days to 24 weeks measured by self-report 3. Self-reported changes in daily cigarette consumption, quit attempts, and changes in motivation and intention to quit in continuing smokers 4. Use of NRT or Zyban or Champix and other smoking cessation aids 5. The number completing the 6-week NHS course 6. Process measures: 6.1. The number of smokers attending the taster session (intervention group only) 6.2. Perception of the personal invitation letters 6.3. Reasons for non-attendance at the taster session and barriers to attendance at the NHS services

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026